Loss of BCL2 modifying factor (BMF), a proapoptotic member of the BCL2 family, was recently shown in a single nucleotide polymorphism (SNP) array study to play a role in the development and relapse of ETV6/RUNX1 positive leukemia [28]. This evidence concerns the gene BMF and leukemia.